Use of meloxicam (amelotex®) in patients with gonarthrosis

Abstract

The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug amelotex® (meloxicam) in patients with gonarthrosis. One-month meloxicam therapy is shown to have a good analgesic effect and tolerability and to improve quality of life in the patients.

Keywords

• osteoarthrosis
• nonsteroidal anti-inflammatory drugs
• meloxicam